TEDCO, Maryland’s economic engine for technology companies, announced a recent $25,000 Pre-Seed Rural Business Innovation Initiative (RBII) Fund investment in Atme. TEDCO’s RBII was designed to enhance technology commercialization and provide technical and business assistance to small and early-stage companies based in rural Maryland.
Higher Medicine is a company working to develop functional cures for Kabuki syndrome (KS) using epigenetic modifying molecules. The business aims to restore the open versus closed chromatin balance, the primary cause of KS, by using an LSD-1 inhibitor and accelerating into a patient clinical study.
TEDCO invests $500,000 from Venture Funds into the TeamWorx Security, an innovative company working to defend some of the most critical industries and enterprises.
Pixee was started to empower enterprise security teams with the platform necessary to match the velocity of software development in today’s generative artificial intelligence (AI) coding era. To do this, the company designed a platform that should integrate directly into developer workflows to create ready-to-merge code improvements that remediate vulnerabilities. The platform seeks to automate expert review of all code scanner findings and provide personalized recommendations on the validity of findings, thus eliminating noise in the code scanner results. Designed with security-conscious enterprises in mind, the platform is offered with an on-premises deployment option in an effort to help keep customers’ sensitive data, intellectual property and source code under the customer's control.
TEDCO’s Concept Capital program was created to provide critical early-stage funding for tech companies in need of assistance to further launch and grow their business, allowing Maryland to become a hub for entrepreneurial success.
Neuros Biotechnology, located in Sunderland, Md., is a neuroregenerative biotechnology start-up working to combat Alzheimer’s disease through neurogenic therapies. Through its process, the company is using a human-derived acellular mixed biologic to rejuvenate neuroplasticity and cognition by activating the naturally occurring neurogenic niche in the temporal lobe, with the intention of halting and reversing the effects of Alzheimer's disease development.
The BII was created to support an equitable innovation and entrepreneurial ecosystem within higher education institutions in the Baltimore-Columbia-Towson Metropolitan Statistical Area (MSA). As part of Maryland’s matching contribution toward the Baltimore Tech Hub, the BII seeks to advance technology toward commercialization of a product or service and bolster support for entrepreneurs developing technology-based ventures.
Irazú Oncology, located in the University of Maryland BioPark in Baltimore, Md., is working to create faster, more cost effective and versatile cancer immunotherapies. Through the Outer Membrane Vesicle (OMV) platform technology, Irazú utilizes outer membrane vesicles – non-replicating, self-adjuvanted, clinically validated, bacteria-derived engineered nanoparticles – to display and deliver tumor antigens for antigen presentation.
Based in College Park, Md., Pathotrak has developed patented technology that aims to reduce the time required for detecting foodborne pathogens, cutting the process from a typical 22-hour enrichment to just five and a half hours. By enabling faster and more efficient testing, Pathotrak is dedicated to helping minimize food waste, reduce the cost of recalls, and improve overall food safety standards.
Sybal Corp., based in North Bethesda, Md., is a software company offering governance solutions. Its patented Proof of Governance® solution aims to reduce the cost and time it takes teams to identify, interpret and correct performance gaps governed by policy.